• Home
  • News
  • Coins2Day 500
    • Coins2Day Global 500
    • Coins2Day 500 Europe
    • Coins2Day China 500
    • Coins2Day SEA 500
    • Great Place To Work
  • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Investing
    • Banking
    • Crypto
  • Leadership
    • Success
    • Future Of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Analytics
  • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Home
  • News
  • Coins2Day 500
    • Coins2Day 500
    • Coins2Day Global 500
    • Coins2Day 500 Europe
    • Coins2Day China 500
    • Coins2Day SEA 500
    • Great Place To Work
  • Tech
    • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Investing
    • Banking
    • Crypto
  • Leadership
    • Leadership
    • Success
    • Future Of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Rankings
    • Analytics
  • Multimedia
    • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Asia
  • Europe
  • Analytics
  1. home
  1. home
  2. sackler family

sackler family

The Sackler family, creators of OxyContin, are trying to protect a dark, twisted empire
Politics

The Sackler family, creators of OxyContin, are trying to protect a dark, twisted empire

By Crypto Correspondent
April 23, 2021
Purdue sign

Sacklers to Remain Billionaire Family If Purdue Settles Opioid Lawsuits

By Tom Maloney, Jef Feeley and Bloomberg
August 28, 2019
US-politics-health-opioids-LAWSUIT

New York Files Charges Against Members of Sackler Family

By Industry Analyst
March 28, 2019
OxyContin 80 mg pills are shot in the studio on August 1, 2013.

OxyContin Outcry Forces Purdue’s Sackler Family to Suspend Arts Donations

By Investment Desk
March 25, 2019
Visitors At Tate Britain In London

Second British Art Gallery Pledges to Reject Donations From Purdue Pharma’s Sackler Family

By Financial Writer
March 22, 2019
sackler-family-opiods-lawsuit

Family Behind Purdue Pharma and OxyContin Faces Multiple Lawsuits

By Market Analyst
November 19, 2018
Oxycontin pills. oxycodone hydrochloride. prescription only pain medication.
Health

OxyContin Billionaire Granted Patent for Opioid Addiction Treatment

By Digital Assets Editor
September 7, 2018
Tennessee, Florida Opioid Suits Create New Settlement Doubts
Health

Massachusetts Sues OxyContin Maker Purdue, Names Executives in Filing

By Industry Analyst
June 13, 2018

Most Popular

  • AI
    Elon Musk says that in 10 to 20 years, work will be optional and money will be irrelevant thanks to AI and robotics
    By Senior Editor
  • Economy
    One of the world’s most popular economists on why AI is ‘undoubtedly going to crash’: It’s built off ‘digital...
    By News Correspondent
  • Big Tech
    Nvidia CEO says the company is in a no-win situation amid AI-bubble chatter, leaked meeting reveals
    By Crypto Correspondent
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • MPW
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms of Use
  • Single Issues for Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work at Coins2Day
  • Diversity and Inclusion
  • Terms and Conditions
  • Site Map

© 2025 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.